The Biomarker Gliostem® will help neurosurgeons distinguish between healthy and cancerous tissue during brain tumor surgery. Celluminova specializes in developing new tools for stem cell research, including cancer stem cells. The patented biomarker GlioStem is intended for the detection and visualization of stem cell-like cells in brain tumors.